MEREDITH DHILLON: Open Payments
NPI 1427531102 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,089 in 156 payments from 18 companies in 2025. Trend: 2023 $779 · 2024 $2,655 · 2025 $3,089
Food & beverage: $3,089
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $517 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $337 |
| Axsome Therapeutics, Inc. | 14 | $301 |
| Neurocrine BioSciences, Inc. | 10 | $278 |
| Collegium Pharmaceutical, Inc. | 12 | $231 |
| E.R. Squibb & Sons, L.L.C. | 8 | $216 |
| Alkermes, Inc. | 12 | $214 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $186 |
| Tris Pharma Inc | 8 | $157 |
| Janssen Pharmaceuticals, Inc | 6 | $137 |
Products named: VRAYLAR, CAPLYTA, Auvelity, INGREZZA, Jornay PM, COBENFY, ARISTADA, REXULTI.
Industry payments across VA — which companies pay providers there.
